allo T-cell is the same as an auto T-cell but has been genetically modified to remove a protein that causes the GvHD (I think it’s a protein, but it’s modifying something) but end of the day, it’s still just a T-cell that’s fighting the cancer, I can’t see how this is going to be any different in success rate to current auto t-cell treatments? From what I’m aware it, you’ll probably still see a similar 60% fail rate
IMU Price at posting:
1.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)